Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
ZTS Insider Transactions (Form 4)
67
119 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 3.
Zoetis Inc. (ZTS) had 12 insider filings in the last 90 days, with the most recent on 2026-08-11. The full record for ZTS runs to 119 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ZTS stock?
No insider purchases of ZTS were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling ZTS stock?
No insider sales of ZTS were filed in the last 90 days. 3 sales are on record for this company.
Where can I see ZTS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ZTS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ZTS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ZTS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.